Gel filtration of sonicates using a sephacryl S 200 HR column (h = 100 cm, r = 0-8 cm; Pharmacia, Uppsala, Sweden) showed the cytotoxic fractions to be clearly distinct from the urease containing fractions.6 To gain further evidence for the independence of this cytotoxic effect from the urease activity, we used AHA (Sigma, St Louis, Missouri, USA) as a urease inhibitor. At a concentration of 0.5 mg/ml, we found the H pylon urease activity to be effectively blocked (data not shown) as has been reported by Mobley et al.1 While the addition of AHA to our cytotoxicity assay at the same concentration did not have an adverse effect on the HeLa cells when given either alone (control) or in combination with the urease fraction or a non-toxic fraction, combination of AHA with the cytotoxic fraction led to a sharp increase of cytotoxic activity (figure). Dr Savio raises two points. The first is an alternative method of transportation, processing, and storage of gastric biopsy cultures for H pylon. In our article we describe a low budget method of transporting gastric biopsy samples, without the need for refrigeration or a specialised transport medium, to a laboratory facility capable of culturing H pylori.
Although we are surprised and impressed by the long delay without loss of viability of the culture method described by Dr Savio, we feel that this method is more tailored to a situation in which facilities (refrigeration, culture media, a microbiology laboratory) are present in the same institution. In our experience, contamination of culture plates in an endoscopy departmnent does occur and can be a problem (especially with yeasts) when culturing a fastidious organism like Hpylori.
The second comment addresses the important point of how to detect or better exclude the presence of H pylori after treatment with drugs (omeprazole, bismuth, and several antibiotics) which influence the number and viability of the bacterium (coccoid forms). As most methods for detecting H pylorn require a certain number of viable bacteria (histology, culture, and breath tests) to detect the bacterium, false negative test results are bound to occur after treatment. This problem is probably not solved by taking more specimens, and is at this moment the subject of further investigation.
In previously untreated patients we found (unpublished data) no positive culture results for H pylon from the gastric body when the gastric antrum was also not infected. In about 20% of our patients no inflammation or infection can be demonstrated in the gastric body region, which does not support the taking of additional body biopsy specimen for routine culture in previously untreated patients. 
